摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 934400-55-2

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
934400-55-2
化学式
C33H49NO5Si
mdl
——
分子量
567.841
InChiKey
JFQTZLGFDHEMCM-UIRBJVBBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.38
  • 重原子数:
    40.0
  • 可旋转键数:
    13.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.52
  • 拓扑面积:
    73.86
  • 氢给体数:
    1.0
  • 氢受体数:
    5.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Molecular Insights into Azumamide E Histone Deacetylases Inhibitory Activity
    摘要:
    Azumamide E, a cyclotetrapeptide isolated from the sponge Mycale izuensis, is the most powerful carboxylic acid containing natural histone deacetylase (HDAC) inhibitor known to date. In this paper, we describe design and synthesis of two stereochemical variants of the natural product. These compounds have allowed us to clarify the influence of side chain topology on the HDAC-inhibitory activity. The present contribution also reveals the identity of the recognition pattern between azumamides and the histone deacetylase-like protein (HDLP) model receptor and reports the azumamide E unprecedented isoform selectivity on histone deacetylases class subtypes. From the present studies, a plausible model for the interaction of azumamides with the receptor binding pocket is derived, providing a framework for the rational design of new cyclotetrapeptide-based HDAC inhibitors as antitumor agents.
    DOI:
    10.1021/ja0686256
  • 作为产物:
    描述:
    5-苄氧基-2-甲基戊烷-1,3-二醇吡啶platinum(IV) oxide 、 palladium on activated charcoal 4-二甲氨基吡啶 、 sodium azide 、 草酰氯氢气二甲基亚砜三乙胺 作用下, 以 四氢呋喃乙醇二氯甲烷乙酸乙酯N,N-二甲基甲酰胺 为溶剂, 反应 6.0h, 生成
    参考文献:
    名称:
    Molecular Insights into Azumamide E Histone Deacetylases Inhibitory Activity
    摘要:
    Azumamide E, a cyclotetrapeptide isolated from the sponge Mycale izuensis, is the most powerful carboxylic acid containing natural histone deacetylase (HDAC) inhibitor known to date. In this paper, we describe design and synthesis of two stereochemical variants of the natural product. These compounds have allowed us to clarify the influence of side chain topology on the HDAC-inhibitory activity. The present contribution also reveals the identity of the recognition pattern between azumamides and the histone deacetylase-like protein (HDLP) model receptor and reports the azumamide E unprecedented isoform selectivity on histone deacetylases class subtypes. From the present studies, a plausible model for the interaction of azumamides with the receptor binding pocket is derived, providing a framework for the rational design of new cyclotetrapeptide-based HDAC inhibitors as antitumor agents.
    DOI:
    10.1021/ja0686256
点击查看最新优质反应信息